Skip to main
IVVD
IVVD logo

Invivyd Inc (IVVD) Stock Forecast & Price Target

Invivyd Inc (IVVD) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 80%
Buy 20%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Invivyd Inc. is positioned for a favorable outlook due to its innovative antibody-based therapies, particularly PEMGARDA, which has demonstrated enduring efficacy against currently dominant SARS-CoV-2 variants, including LP.8.1, XEC, and KP.3.1.1. The company's focus on high-risk populations, specifically immunocompromised individuals, highlights a strategic approach to capture a significant market segment, especially as the demand for effective pre-exposure prevention continues to rise. Additionally, positive Phase 3 data and the anticipation of improved launch trajectories in 2025 further underscore the potential for revenue growth, driven by robust clinical evidence and the ongoing development of advanced candidates like VYD2311.

Bears say

Invivyd Inc faces significant regulatory challenges that have negatively impacted its stock outlook, particularly highlighted by the FDA's rejection of the company's request to expand the Emergency Use Authorization (EUA) of its treatment PEMGARDA for mild-to-moderate COVID-19. This setback emphasizes the difficulties in securing approvals for COVID-19 therapeutics, suggesting that a lack of diversification in the company's pipeline may hinder its long-term growth potential. Furthermore, the decision leaves a vulnerable patient population without access to effective monoclonal antibody treatments, raising concerns about the company's ability to generate revenues and maintain investor confidence.

Invivyd Inc (IVVD) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 80% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Invivyd Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Invivyd Inc (IVVD) Forecast

Analysts have given Invivyd Inc (IVVD) a Strong Buy based on their latest research and market trends.

According to 5 analysts, Invivyd Inc (IVVD) has a Strong Buy consensus rating as of Aug 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5.51, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5.51, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Invivyd Inc (IVVD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.